Nicholas Spellmon

439 citations
16 papers · 291 · h-index 9

Impact in

    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation
    • RNA modifications and cancer
    • Protein Structure and Dynamics
    • Histone Deacetylase Inhibitors Research
    • RNA and protein synthesis mechanisms

Papers in

    • Epigenetics and DNA Methylation 5
    • Cancer-related gene regulation 4
    • RNA modifications and cancer 3
    • Glycosylation and Glycoproteins Research 2
    • Virus-based gene therapy research 2

Nicholas Spellmon

14 papers receiving 288 citations

Peers

Nicholas Spellmon
Comparison fields: 5 of 70
  • Molecular Biology 210
  • Endocrinology 11
  • Molecular Medicine 8
  • Genetics 34
  • Infectious Diseases 22
Replace Simon Goto with:
Simon Goto Japan
Gundeep Kaur United States
Benjamin B. Johnson United Kingdom
Preston Hunter United States
Miharu Hisaoka Japan
A. K. M. Firoj Mahmud Sweden
Bharanidharan Devarajan India
Leandra Brettner United States
Venkataramanan Soundararajan United States
Joana Sales-Dias Portugal
Nicholas Spellmon relative to Simon Goto Japan Simon Goto's profile →
Citations per field
00.5×1.5×
Simon Goto · 1×
Citations per year

Countries citing papers authored by Nicholas Spellmon

Since Specialization
Citations

This map shows the geographic impact of Nicholas Spellmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Spellmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Spellmon more than expected).

Fields of papers citing papers by Nicholas Spellmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Spellmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Spellmon. The network helps show where Nicholas Spellmon may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicholas Spellmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicholas Spellmon Line = papers co-authored together Nicholas Spellmon links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2015107
2 202032
3 201731
4 201823
5 201721
6 201514
7 201913
8 202210
9 201610
10 20157
11 20187
12 20176
13 20166
14 20214
15 20250
16 20150

About Nicholas Spellmon

Nicholas Spellmon is a scholar working on Molecular Biology, Genetics, Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology, having authored 16 papers that have together received 291 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (4 papers), RNA modifications and cancer (3 papers), Cystic Fibrosis Research Advances (2 papers), Virus-based gene therapy research (2 papers), Glycosylation and Glycoproteins Research (2 papers), interferon and immune responses (2 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Molecular Biology (210 citations), Endocrinology (11 citations), Molecular Medicine (8 citations), Genetics (34 citations) and Infectious Diseases (22 citations). Nicholas Spellmon has collaborated with scholars based in United States and Thailand. Frequent co-authors include Zhe Yang, Joshua Holcomb, Nualpun Sirinupong, Chunying Li, Jochen Zimmer, Yingxue Zhang, Franck Amblard, Xiaonan Sun, Ladislau C. Kovari and J.S. Brunzelle. Their work appears in journals such as Biochemical and Biophysical Research Communications, Nature Communications, PLoS ONE, Current Drug Targets and Annual Review of Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact